Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GVGH iNTS-TCV Vaccine in Infants in Africa
NCT07286370Phase 2Recruiting
- Sponsor
- GSK
- Start
- Apr 2026
- Primary completion
- Apr 2028
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of iNTS-TCV in salmonellosis, typhoid fever, sponsored by GSK. Started Apr 2026; status: recruiting.
02
Drugs
iNTS-TCV
03
Conditions
salmonellosistyphoid fever
Beyond the preview
Go deeper on NCT07286370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07286370.